Fact CheckerSign in

NCT05946044Recruiting

The Osteoarthritis Prevention Study

Source: ClinicalTrials.gov · Last updated 23 Jul 2026

Brief summary (registry, in English)

The goal of this study is to establish the efficacy of an intervention of dietary weight loss, exercise, and weight-loss maintenance for knee Osteoarthritis (OA) prevention in adult females aged ≥ 50 years with obesity and no or infrequent knee pain. The primary aim is to compare the effects of a dietary weight loss, exercise, and weight-loss maintenance to an attention control group in preventing the development of structural Magnetic Resonance Imaging (MRI) knee OA. Secondary aims will determine the intervention effects on pain, mobility, health-related quality of life, knee joint compressive forces, inflammatory measures, weight loss, exercise self-efficacy, and cost-effectiveness of this intervention.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1230 (estimated)
First submitted
6 Jul 2023
Start date
21 Mar 2024
Primary completion date
31 Jul 2029
Lead sponsor
Wake Forest University
Diseases
Obesity
NCT number
NCT05946044

What you commit to

  • Study type: Interventional
  • Planned participants: 1230
  • From 21 Mar 2024 to the primary completion date, 31 Jul 2029
  • 4 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • during the past 12 months knee fracture, anterior cruciate ligament (ACL), medial collateral ligament (MCL), or meniscus injury with or without surgical repair

Other illness

  • symptomatic or severe coronary artery disease
  • type 1 diabetes
  • active treatment for cancer

Other

  • unable to walk without a device
  • blindness
  • knee injection during the past 6 months
  • bilateral knee OA by x-ray Kellgren-Lawrence (KL) ≥ 2
  • bilateral knee OA by MRI
  • bilateral symptomatic knee OA (frequent bilateral knee pain \> 15 days per month)
  • BMI\< 30.0 kg/m2
  • male sex
  • claustrophobia
  • contraindication to MRI including body weight \> 300 lbs or knee coil does not fit
  • unwillingness or inability to change eating and physical activity habits due to environment
  • cannot speak and read English
  • planning to leave area \> 2 months during the 48-month intervention period

Who the study is looking for

  • Female
  • BMI ≥ 30 kg/m2
  • An eligible knee will have no OA by xray and MRI
  • No or infrequent knee pain (\< 15 days/month) in the same knee

Age in the registry: 50 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Sydney
Coordinator of this site? Confirm its status
SydneyAustraliaRecruiting
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
University of North Carolina at Chapel Hill
Coordinator of this site? Confirm its status
Chapel HillUnited StatesActive, not recruiting
Wake Forest University
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.